Primary study · included by 1 review

The Efficacy of Low-Level Laser Therapy in Burning Mouth Syndrome – A Pilot Study

Sikora 2018 · Sikora Miroslav · Acta Clinica Croatica · 2018

Included by

Advanced, pharmacological and complementary interventions for chronic or recurrent orofacial pain conditions: a systematic evidence map with selective meta-analyses.

Non-Cochrane · intervention · 2026 · cited as Sikora 2018 · Reference list (ref 119); Supplementary Table 4

Outcome this study informs	Pooled effect	Evidence	Certainty
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -1.00 [-1.98, -0.02]	2 studies	GRADE not reported
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -1.00 [-1.98, -0.03]	NR	GRADE not reported
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -0.75 [-1.24, -0.26]	3 studies	GRADE not reported
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -0.42 [-0.67, -0.16]	2 studies	GRADE not reported
Pain intensity Photobiomodulation / low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate to 4 weeks)	SMD -0.76 [-1.09, -0.43]	3 studies · 200 participants	GRADE not reported
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -0.86 [-1.44, -0.29]	2 studies	GRADE not reported
Pain intensity Photobiomodulation / low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate to 4 weeks)	SMD -0.81 [-1.35, -0.27]	3 studies · 200 participants	GRADE not reported
Pain intensity Photobiomodulation or low-level laser therapy (PBM/LLLT) vs Inactive control (placebo, sham, usual care or no intervention) · Short-term (immediate post-intervention to 4 weeks)	SMD -0.81 [-1.35, -0.27]	3 studies · 200 participants	Moderate

1 including review in total.